SNX-0723

CAS No. 1073969-18-2

SNX-0723( SNX 0723 | SNX0723 )

Catalog No. M10305 CAS No. 1073969-18-2

SNX-0723 is a selective, brain-permeable, orally acitve small-molecule inhibitor of Hsp90 (IC50=14 nM) that inhibits alpha-synuclein oligomerization with EC50 of 48 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 312 Get Quote
10MG 500 Get Quote
25MG 807 Get Quote
50MG 1107 Get Quote
100MG 1485 Get Quote
500MG 2961 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SNX-0723
  • Note
    Research use only, not for human use.
  • Brief Description
    SNX-0723 is a selective, brain-permeable, orally acitve small-molecule inhibitor of Hsp90 (IC50=14 nM) that inhibits alpha-synuclein oligomerization with EC50 of 48 nM.
  • Description
    SNX-0723 is a selective, brain-permeable, orally acitve small-molecule inhibitor of Hsp90 (IC50=14 nM) that inhibits alpha-synuclein oligomerization with EC50 of 48 nM; induces Hsp70 (IC50=31 nM), and decreases expression of several known Hsp90 client proteins:HER2 (IC50=9.4 nM), ribosomal protein s6 (pS6) (IC50=13 nM), and PERK (IC50=5.5 nM); shows significant brain concentrations along with induction of brain Hsp70 in vivo with promising PK properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SNX 0723 | SNX0723
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1073969-18-2
  • Formula Weight
    399.47
  • Molecular Formula
    C22H26FN3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20.83 mg/mL (52.15 mM)
  • SMILES
    O=C(N)C1=C(N[C@@H]2COCC2)C=C(N3C=C(C)C4=C3CC(C)(C)CC4=O)C=C1F
  • Chemical Name
    2-fluoro-6-[[(3S)-oxolan-3-yl]amino]-4-(3,6,6-trimethyl-4-oxo-5,7-dihydroindol-1-yl)benzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Putcha P, J Pharmacol Exp Ther. 2010 Mar;332(3):849-57.et al. 2. McFarland NR, et al. PLoS One. 2014 Jan 20;9(1):e86048. 3. Neubert T, et al. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1338-42.
molnova catalog
related products
  • Momordin Ic

    Momordin Ic might represent a potential anticancer activity, by inducing apoptosis through oxidative stress-regulated mitochondrial dysfunction involving the MAPK and PI3K-mediated iNOS and HO-1 pathways.

  • DTHIB

    DTHIB robustly inhibits the HSF1 cancer gene signature and prostate cancer cell proliferation.

  • HS-27

    HS-27 is a fluorescently-tethered inhibitor of Hsp90 with SNX-5422 tethered via a PEG linker to a fluorescein isothiocyanate or FITC. HS-27 can be used in see-and-treat paradigms.